39497295|t|Effect of ceftriaxone on the glutamate-glutamine cycle and seizure susceptibility of Tg2576 mouse model of Alzheimer's disease.
39497295|a|BACKGROUND: Individuals with Alzheimer's disease (AD) have a heightened risk of epilepsy. However, the underlying mechanisms are not well-understood. OBJECTIVE: We aimed to elucidate the role of the glutamate-glutamine cycle in this mechanism and test the effect of ceftriaxone, a glutamate transporter-1 (GLT-1) enhancer, on seizure susceptibility in the Tg2576 mouse model of AD. METHODS: First, we assessed expression levels of key proteins in the glutamate-glutamine cycle in Tg2576 (n = 7) and wild-type littermates (n = 7), and subsequently in the kindling model of epilepsy (n = 6) and sham (n = 6). Then, kindling susceptibility was assessed in three groups: 200 mg/kg ceftriaxone-treated Tg2576 (Tg-Ceft, n = 9); saline-treated Tg2576 (Tg-Sal, n = 9); and saline-treated wild-type (WT-Sal, n = 15). Mice were treated for seven days before kindling, and seizure susceptibility compared between groups. RESULTS: Protein levels of GLT-1 (p = 0.0093) and glutamine synthetase (p = 0.0016) were reduced in cortex of Tg2576 mice, compared to WT. Kindling increased GLT-1 (cortex: p < 0.0001, hippocampus: p = 0.0075), and glutaminase (cortex: p = 0.0044) protein levels, compared to sham. Both Tg-Ceft and WT-Sal displayed Class IV seizures in response to the first stimulation (p > 0.99), while Tg-Sal displayed Class V seizure (p = 0.0212 versus WT-Sal). Seizure susceptibility of Tg-Ceft was not different from Tg-Sal (p > 0.05), and kindling rates did not differ between groups. CONCLUSIONS: Disruptions to key components of the glutamate-glutamine cycle are observed in models of AD and epilepsy. However, increasing GLT-1 through ceftriaxone treatment did not influence seizure susceptibility in Tg2576 mice, suggesting this is not an effective strategy to lower seizure susceptibility in AD, or a higher dosage is needed.
39497295	10	21	ceftriaxone	Chemical	MESH:D002443
39497295	29	38	glutamate	Chemical	MESH:D018698
39497295	39	48	glutamine	Chemical	MESH:D005973
39497295	59	66	seizure	Disease	MESH:D012640
39497295	85	91	Tg2576	CellLine	CVCL:S723
39497295	92	97	mouse	Species	10090
39497295	107	126	Alzheimer's disease	Disease	MESH:D000544
39497295	157	176	Alzheimer's disease	Disease	MESH:D000544
39497295	178	180	AD	Disease	MESH:D000544
39497295	208	216	epilepsy	Disease	MESH:D004827
39497295	327	336	glutamate	Chemical	MESH:D018698
39497295	337	346	glutamine	Chemical	MESH:D005973
39497295	394	405	ceftriaxone	Chemical	MESH:D002443
39497295	409	432	glutamate transporter-1	Gene	20511
39497295	434	439	GLT-1	Gene	20511
39497295	454	461	seizure	Disease	MESH:D012640
39497295	484	490	Tg2576	CellLine	CVCL:S723
39497295	491	496	mouse	Species	10090
39497295	506	508	AD	Disease	MESH:D000544
39497295	579	588	glutamate	Chemical	MESH:D018698
39497295	589	598	glutamine	Chemical	MESH:D005973
39497295	608	614	Tg2576	CellLine	CVCL:S723
39497295	700	708	epilepsy	Disease	MESH:D004827
39497295	805	816	ceftriaxone	Chemical	MESH:D002443
39497295	825	831	Tg2576	CellLine	CVCL:S723
39497295	865	871	Tg2576	CellLine	CVCL:S723
39497295	936	940	Mice	Species	10090
39497295	990	997	seizure	Disease	MESH:D012640
39497295	1065	1070	GLT-1	Gene	20511
39497295	1088	1108	glutamine synthetase	Gene	14645
39497295	1148	1154	Tg2576	CellLine	CVCL:S723
39497295	1155	1159	mice	Species	10090
39497295	1196	1201	GLT-1	Gene	20511
39497295	1253	1264	glutaminase	Gene	14660
39497295	1363	1371	seizures	Disease	MESH:D012640
39497295	1452	1459	seizure	Disease	MESH:D012640
39497295	1488	1495	Seizure	Disease	MESH:D012640
39497295	1664	1673	glutamate	Chemical	MESH:D018698
39497295	1674	1683	glutamine	Chemical	MESH:D005973
39497295	1716	1718	AD	Disease	MESH:D000544
39497295	1723	1731	epilepsy	Disease	MESH:D004827
39497295	1753	1758	GLT-1	Gene	20511
39497295	1767	1778	ceftriaxone	Chemical	MESH:D002443
39497295	1807	1814	seizure	Disease	MESH:D012640
39497295	1833	1839	Tg2576	CellLine	CVCL:S723
39497295	1840	1844	mice	Species	10090
39497295	1900	1907	seizure	Disease	MESH:D012640
39497295	1926	1928	AD	Disease	MESH:D000544
39497295	Association	MESH:D002443	MESH:D018698
39497295	Association	MESH:D002443	MESH:D005973
39497295	Association	MESH:D005973	20511
39497295	Association	MESH:D018698	MESH:D000544
39497295	Association	MESH:D005973	MESH:D018698
39497295	Association	MESH:D002443	MESH:D012640
39497295	Positive_Correlation	MESH:D002443	20511

